BioSpace News Archive

NRx Pharmaceuticals, a clinical-stage, biopharmaceutical company, provided a business update and financial results for the quarter ended September 30, 2021.

CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced it has initiated the resubmission of its Biologics License Application for HIV under rolling review consistent with guidance from the U.S. Food and Drug Administration.

DNA Script, a leader in Enzymatic DNA Synthesis, announced that Blanche Savary de Beauregard has joined the company as General Counsel.

CB Scientific. Inc. is pleased to announce that it has submitted its application to uplist to the OTCQB® Venture Market.

ImmunoGen Inc. today announced that Kristen Harrington-Smith has been appointed Senior Vice President and Chief Commercial Officer.

Codiak BioSciences, Inc. today announced positive initial data for exoSTING, a novel engineered exosome therapeutic candidate currently being investigated in a Phase 1/2 clinical trial as a single agent for the treatment of multiple solid tumors.

NanoViricides, Inc. has filed its quarterly report for its first quarter of financial year 2022 with the Securities and Exchange Commission.

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative gamma-delta T cell therapies utilizing its DeltEx platform, today announced the appointment of Trishna Goswami, M.D. as Chief Medical Officer.

AIM ImmunoTech Inc. (NYSE American: AIM) announces financial results for the third quarter ended September 30, 2021 and provides a business update.

Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, announced that multiple presentations were given at the American Academy of Ophthalmology 2021, which took place November 12 - 15, 2021 in New Orleans, LA.